ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,631Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 1269

$828K Total Retail Price of All Prescriptions

Rank: 42 out of 1269

524 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 524 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 524 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 16,924 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 902 895 1 4
FUROSEMIDE 636 609 2 5
MIRTAZAPINE 463 461 3 24
METOPROLOL TARTRATE 447 446 4 6
DONEPEZIL HCL 416 415 5 22
WARFARIN SODIUM 364 359 6 12
OMEPRAZOLE 355 348 7 8
AMLODIPINE BESYLATE 350 345 8 2
CITALOPRAM HBR 341 332 9 21
SERTRALINE HCL 331 330 10 23
LISINOPRIL 291 290 11 1
TRAMADOL HCL 273 252 12 16
POTASSIUM CHLORIDE 271 271 13 26
GABAPENTIN 265 244 14 17
PREDNISONE 264 241 15 45
NAMENDA 249 248 16 38
PRAVASTATIN SODIUM 249 246 16 11
METOPROLOL SUCCINATE 229 229 18 13
SIMVASTATIN 205 202 19 3
PANTOPRAZOLE SODIUM 204 204 20 18
QUETIAPINE FUMARATE 201 194 21 53
TRAZODONE HCL 200 192 22 36
LIDODERM 197 195 23 56
TAMSULOSIN HCL 183 183 24 31
RISPERIDONE 181 181 25 43
CARBIDOPA-LEVODOPA 181 181 25 78
ATENOLOL 177 177 27 14
DIVALPROEX SODIUM 177 171 27 54
CARVEDILOL 172 161 29 29
LYRICA 169 149 30 92
ESCITALOPRAM OXALATE 168 158 31 58
NITROFURANTOIN MONO-MACRO 156 144 32 198
HYDROCHLOROTHIAZIDE 153 148 33 10
ATORVASTATIN CALCIUM 145 145 34 7
POLYETHYLENE GLYCOL 3350 142 137 35 50
DIGOXIN 134 134 36 62
FLUTICASONE PROPIONATE 125 107 37 40
HYDROCODONE-ACETAMINOPHEN 120 104 S3 38 20
METFORMIN HCL 115 107 39 9
CIPROFLOXACIN HCL 114 109 40 66
KLOR-CON M20 113 109 41 60
SEROQUEL 113 112 41 104
DIOVAN 109 100 43 35
SPIRONOLACTONE 105 105 44 77
JANTOVEN 105 105 44 52
CEPHALEXIN 104 96 46 113
CLOPIDOGREL 100 98 47 32
ZOLPIDEM TARTRATE 100 98 47 19
VENLAFAXINE HCL ER 97 97 49 140
CYMBALTA 96 85 50 70
AZITHROMYCIN 95 86 51 42
LEVETIRACETAM 93 72 52 55
PAROXETINE HCL 92 77 53 71
GLIPIZIDE 90 86 54 37
OLANZAPINE 84 81 55 89
EXELON 83 83 56 142
FINASTERIDE 81 81 57 112
ALENDRONATE SODIUM 79 78 58 28
LOSARTAN POTASSIUM 77 71 59 15
HYDRALAZINE HCL 75 70 60 48
ALLOPURINOL 74 71 61 49
LATANOPROST 72 72 62 143
LEVOFLOXACIN 69 68 63 75
BUPROPION HCL 67 62 64 341
RANITIDINE HCL 66 63 65 27
PLAVIX 65 64 66 47
IPRATROPIUM-ALBUTEROL 65 65 66 86
DILTIAZEM 24HR ER 65 61 66 204
AMIODARONE HCL 64 64 69 166
LOPERAMIDE 64 64 69 212
MECLIZINE HCL 64 62 69 140
OXYBUTYNIN CHLORIDE 61 61 72 128
LOVASTATIN 59 59 73 30
LACTULOSE 58 55 74 67
ROPINIROLE HCL 57 55 75 151
RAMIPRIL 57 57 75 96
NYSTATIN 56 52 77 119
TIMOLOL MALEATE 56 56 77 293
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 55 79 84
FLUOXETINE HCL 54 54 80 83
ISOSORBIDE MONONITRATE ER 52 52 81 63
NITROFURANTOIN 50 47 82 210
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 13, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.